Source: DGNews | Posted 9 years ago
FDA Approves Aralast Alpha-1 Proteinase Inhibitor Augmentation Treatment For Congenital Deficiency, Emphsysema
Tags:
LOS ANGELES, CA and DEERFIELD, IL -- January 9, 2003 -- Alpha Therapeutic Corporation (Alpha) and Baxter Healthcare Corporation (Baxter) today announced that Alpha has received U.S. Food and Drug Administration (FDA) authorization for Aralast
Comments